LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$81.50 USD
+0.91 (1.13%)
Updated Jun 21, 2024 04:00 PM ET
After-Market: $81.48 -0.02 (-0.02%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth C Momentum D VGM
Brokerage Reports
LeMaitre Vascular, Inc. [LMAT]
Reports for Purchase
Showing records 161 - 180 ( 191 total )
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
2Q 2014: Quarterly Medical Technology Trading & Acquisition Valuation UpdateThis report contains brief updates on the following: ALGN, BABY, ETRM, EXAS, ICUI, LMAT, MASI, NSPH, TEAR, TRIB, UPI, VOLC. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Hit on the Top Line and a Miss on the Bottom- Line--but Things Should Improve Quickly
Provider: The Benchmark Company
Analyst: WALD J
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Mixed 1Q but 2014 Still Intact; Cost Initiatives to Drive 2H14 Leverage
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
1Q Preview: Risk-Reward Profile Remains Attractive
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Healthcare: 1Q 2014: Quarterly Medical Technology Trading & Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Healthcare -2014 Conference - Med Tech "Cheat Sheet"
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Good Growth, Expansion More Than Makes Up for Lower Margins
Provider: The Benchmark Company
Analyst: WALD J
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Solid 4Q Despite Margin Pressures; 2014 Revenue Guidance Exceeds; Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
4Q Preview: Expecting Inline 4Q, ''14 Guide; Risk-Reward Remains Attractive
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Encouraging Analyst Day Takeaways - Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Morning Call
Provider: The Benchmark Company